Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
about
Simplified Reversed Chloroquines To Overcome Malaria Resistance to Quinoline-Based DrugsQuantification of Plasmodium ex vivo drug susceptibility by flow cytometry.Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes.SLCO1A2, SLCO1B1 and SLCO2B1 polymorphisms influences chloroquine and primaquine treatment in Plasmodium vivax malaria.Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia.Antimalarial activity of Malaria Box Compounds against Plasmodium falciparum clinical isolates.
P2860
Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Contrasting ex vivo efficacies ...... ciparum and P. vivax isolates.
@ast
Contrasting ex vivo efficacies ...... ciparum and P. vivax isolates.
@en
type
label
Contrasting ex vivo efficacies ...... ciparum and P. vivax isolates.
@ast
Contrasting ex vivo efficacies ...... ciparum and P. vivax isolates.
@en
prefLabel
Contrasting ex vivo efficacies ...... ciparum and P. vivax isolates.
@ast
Contrasting ex vivo efficacies ...... ciparum and P. vivax isolates.
@en
P2093
P2860
P50
P921
P356
P1476
Contrasting ex vivo efficacies ...... ciparum and P. vivax isolates.
@en
P2093
Boni F Sebayang
Ferryanto Chalfein
Grennady Wirjanata
Irene Handayuni
Jutta Marfurt
Steven J Burgess
P2860
P304
P356
10.1128/AAC.01048-15
P407
P577
2015-07-06T00:00:00Z